"People are trading equities almost as a macro yield-baring instrument as opposed to valuing individual companies and performances," said Blankfein. "One of the risks that are inherent in this interest rate policy that we have is that assets are being pumped up almost indiscriminately. That's not necessarily a good market for people like ourselves."
Blankfein also discussed the firm's move into consumer lending and provided an update on his fight with cancer.
To watch the broadcast interview in its entirety, you must be a CNBC PRO subscriber .